Guggenheim Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $372K | Buy |
|
|||||
|
2025
Q2 | $314K | Sell |
|
|||||
|
2025
Q1 | $585K | Sell |
|
|||||
|
2024
Q4 | $281K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $205K | Sell |
|
|||||
|
2023
Q2 | $443K | Sell |
|
|||||
|
2023
Q1 | $704K | Buy |
|
|||||
|
2022
Q4 | $382K | Sell |
|
|||||
|
2022
Q3 | $555K | Sell |
|
|||||
|
2022
Q2 | $524K | Sell |
|
|||||
|
2022
Q1 | $540K | Buy |
|
|||||
|
2021
Q4 | $433K | Sell |
|
|||||
|
2021
Q3 | $1.26M | Buy |
|
|||||
|
2021
Q2 | $498K | Sell |
|
|||||
|
2021
Q1 | $575K | Sell |
|
|||||
|
2020
Q4 | $1.19M | Buy |
|
|||||
|
2020
Q3 | $179K | Sell |
|
|||||
|
2020
Q2 | $261K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $210K | Buy |
|
|||||
|
2019
Q3 | $234K | Sell |
|
|||||
|
2019
Q2 | $242K | Sell |
|
|||||
|
2019
Q1 | $405K | Sell |
|
|||||
|
2018
Q4 | $637K | Sell |
|
|||||
|
2018
Q3 | $1.5M | Buy |
|
|||||
|
2018
Q2 | $1.39M | Sell |
|
|||||
|
2018
Q1 | $3.92M | Buy |
|
|||||
|
2017
Q4 | $3.81M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $213K | Sell |
|
|||||
|
2016
Q4 | $193K | Sell |
|
|||||
|
2016
Q3 | $184K | Sell |
|
|||||
|
2016
Q2 | $163K | Buy |
|
|||||
|
2016
Q1 | $132K | Buy |
|